Edmond De Rothschild Holding S.A. Erytech Pharma S.A. Transaction History

Edmond De Rothschild Holding S.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$11.17 - $21.41 $6,366 - $12,203	-570 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$17.93 - $30.3 $10,220 - $17,271	570	570 $13,000

Ticker ERYP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,018,600
Market Cap $16.8M
Description
ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.